1	Crown	crown	NNP	p2=NN	2	nn	_
2	Biosciences	biosciences	NNP	p2=NNPS	4	nsubj	4:A0=PAG
3	has	have	VBZ	_	4	aux	_
4	partnered	partner	VBN	pb=partner.01	0	root	_
5	with	with	IN	_	4	prep	_
6	China	china	NNP	_	9	poss	_
7	's	's	POS	_	6	possessive	_
8	biggest	big	JJS	_	9	amod	_
9	producer	producer	NN	_	5	pobj	_
10	of	of	IN	_	9	prep	_
11	mutant	mutant	JJ	_	12	amod	_
12	mice	mouse	NNS	_	10	pobj	_
13	to	to	TO	_	14	aux	_
14	build	build	VB	pb=build.01	4	xcomp	4:A1=COM
15	better	well	RBR	p2=JJR	17	amod	_
16	experimental	experimental	JJ	_	17	amod	_
17	models	model	NNS	_	14	dobj	14:A1=PRD
18	for	for	IN	_	17	prep	_
19	its	its	PRP$	_	22	poss	_
20	cancer	cancer	NN	_	21	nn	_
21	research	research	NN	_	22	nn	_
22	sponsors	sponsor	NNS	_	18	pobj	_
23	,	,	,	_	17	punct	_
24	as	as	IN	_	14	prep	_
25	part	part	NN	_	24	pobj	_
26	of	of	IN	_	25	prep	_
27	its	its	PRP$	_	36	poss	_
28	$	$	$	_	30	quantmod	_
29	26.5	0	CD	_	30	number	_
30	m	m	CD	p2=NN	36	nn	_
31	(	(	-LRB-	_	36	punct	_
32	£16	£0	CD	p2=NN	33	num	_
33	m	m	NN	p2=LS	36	nn	_
34	)	)	-RRB-	_	36	punct	_
35	venture	venture	NN	_	36	nn	_
36	funding	funding	NN	_	26	pobj	_
37	.	.	.	_	4	punct	_

1	The	the	DT	_	4	det	_
2	National	national	NNP	_	4	nn	_
3	Resource	resource	NNP	_	4	nn	_
4	Centre	centre	NNP	_	0	root	19:A0=PAG;12:A1=PPT
5	for	for	IN	_	4	prep	_
6	Mutant	mutant	NNP	p2=JJ	7	nn	_
7	Mice	mice	NNP	_	5	pobj	_
8	(	(	-LRB-	_	4	punct	_
9	NRCMM	nrcmm	NNP	_	4	appos	_
10	)	)	-RRB-	_	4	punct	_
11	,	,	,	_	4	punct	_
12	based	base	VBN	pb=base.01	4	partmod	_
13	in	in	IN	_	12	prep	12:AM-LOC
14	Nanjing	nanjing	NNP	_	15	nn	_
15	University	university	NNP	_	13	pobj	_
16	,	,	,	_	15	punct	_
17	China	china	NNP	_	15	appos	_
18	,	,	,	_	19	punct	_
19	breeds	breed	VBZ	p2=NNS|pb=breed.01	0	root	_
20	genetically	genetically	RB	_	21	advmod	21:AM-MNR
21	engineered	engineer	VBN	pb=engineer.01	23	amod	_
22	mutant	mutant	JJ	_	23	amod	_
23	mice	mouse	NNS	p2=NN	19	dobj	19:A1=PPT;21:A1=PPT
24	(	(	-LRB-	_	23	punct	_
25	GEMMs	gemms	NNP	p2=NNS	23	appos	_
26	)	)	-RRB-	_	23	punct	_
27	,	,	,	_	19	punct	_
28	often	often	RB	_	30	advmod	30:AM-TMP
29	to	to	TO	_	30	aux	_
30	be	be	VB	pb=be.01	19	advcl	_
31	immune	immune	JJ	p2=RB	33	hmod	_
32	-	-	HYPH	p2=:	33	hyph	_
33	deficient	deficient	JJ	p2=NN	30	acomp	30:A2=PRD
34	so	so	IN	p2=RB	38	mark	_
35	they	they	PRP	_	38	nsubjpass	38:A1=PPT
36	can	can	MD	_	38	aux	38:AM-MOD
37	be	be	VB	_	38	auxpass	_
38	engrafted	engraft	VBN	pb=engraft.01	30	advcl	_
39	with	with	IN	_	38	prep	38:A2=PPT
40	human	human	JJ	_	41	amod	_
41	cells	cell	NNS	_	39	pobj	_
42	.	.	.	_	19	punct	_

1	Crown	crown	NNP	p2=NN	2	nsubj	2:A0=PAG
2	told	tell	VBD	pb=tell.01	0	root	_
3	Outsourcing	outsourcing	NNP	p2=VBG	5	hmod	_
4	-	-	HYPH	p2=:	5	hyph	_
5	Pharma.com	#url#	ADD	_	2	dobj	2:A2=GOL
6	it	it	PRP	_	7	nsubj	7:A0=PAG
7	chose	choose	VBD	pb=choose.01	2	ccomp	2:A1=PPT
8	NRCMM	nrcmm	NNP	_	7	dobj	7:A1=PPT
9	for	for	IN	_	7	prep	7:AM-CAU
10	the	the	DT	_	11	det	_
11	partnership	partnership	NN	_	9	pobj	_
12	because	because	IN	_	15	mark	_
13	its	its	PRP$	_	14	poss	_
14	GEMMs	gemms	NNP	p2=NNS	15	nsubj	15:A1=PPT
15	are	be	VBP	pb=be.01	7	advcl	7:AM-CAU
16	"	"	``	_	15	punct	_
17	better	good	JJR	p2=RBR	15	acomp	15:A2=PRD
18	than	than	IN	_	17	prep	_
19	others	other	NNS	_	18	pobj	_
20	in	in	IN	_	19	prep	_
21	China	china	NNP	_	20	pobj	_
22	"	"	''	p2=``	2	punct	_
23	because	because	IN	_	25	mark	_
24	they	they	PRP	_	25	nsubj	25:A1=PPT
25	are	be	VBP	pb=be.01	17	advcl	_
26	"	"	``	p2=''	25	punct	_
27	more	more	RBR	_	28	advmod	_
28	deficient	deficient	JJ	_	25	acomp	25:A2=PRD
29	in	in	IN	_	28	prep	_
30	their	their	PRP$	_	31	poss	_
31	immunity	immunity	NN	_	29	pobj	_
32	"	"	``	p2=''	33	punct	_
33	than	than	IN	_	25	prep	_
34	rivals	rival	NNS	_	33	pobj	_
35	'	'	''	_	34	possessive	_
36	.	.	.	_	2	punct	_

1	This	this	DT	_	2	nsubj	2:A0=PAG
2	make	make	VB	p2=VBP|pb=make.02	17	ccomp	17:A1=PPT
3	it	it	PRP	_	4	nsubj	_
4	easier	easy	JJR	p2=RBR	2	ccomp	2:A1=PRD
5	for	for	IN	_	8	mark	_
6	Crown	crown	NNP	_	8	nsubj	8:A0=PAG
7	to	to	TO	p2=IN	8	aux	_
8	engraft	engraft	VB	pb=engraft.01	4	advcl	_
9	human	human	JJ	_	11	amod	_
10	cancer	cancer	NN	_	11	nn	_
11	tissue	tissue	NN	_	8	dobj	8:A1=PPT
12	without	without	IN	_	8	prep	8:AM-MNR
13	it	it	PRP	_	15	nsubjpass	15:A1=PPT
14	being	be	VBG	_	15	auxpass	_
15	rejected	reject	VBN	pb=reject.01	12	pcomp	_
16	,	,	,	_	17	punct	_
17	said	say	VBD	pb=say.01	0	root	_
18	Henry	henry	NNP	_	19	nn	_
19	Li	li	NNP	_	17	nsubj	17:A0
20	,	,	,	_	19	punct	_
21	VP	vp	NNP	p2=NN	24	nn	_
22	of	of	IN	_	21	prep	_
23	Translation	translation	NN	p2=NNP	22	pobj	_
24	Oncology	oncology	NNP	p2=NN	19	appos	_
25	at	at	IN	_	24	prep	_
26	Crown	crown	NNP	_	25	pobj	_
27	.	.	.	_	17	punct	_

1	Crown	crown	NNP	p2=NN	19	nsubj	19:A0=PAG
2	,	,	,	_	1	punct	_
3	a	a	DT	_	6	det	_
4	contract	contract	NN	_	5	nn	_
5	research	research	NN	_	6	nn	_
6	organisation	organisation	NN	_	1	appos	11:A0=PAG
7	(	(	-LRB-	_	6	punct	_
8	CRO	cro	NNP	p2=NN	6	appos	_
9	)	)	-RRB-	_	6	punct	_
10	which	which	WDT	_	11	nsubj	11:R-A0
11	deals	deal	VBZ	pb=deal.01	6	rcmod	_
12	only	only	RB	_	13	advmod	_
13	with	with	IN	_	11	prep	11:A1=PPT
14	cancer	cancer	NN	_	13	pobj	_
15	and	and	CC	_	14	cc	_
16	diabetes	diabetes	NN	_	17	nn	_
17	R&D	r&d	NN	p2=NNP	14	conj	_
18	,	,	,	_	1	punct	_
19	announced	announce	VBD	p2=VBN|pb=announce.01	0	root	_
20	last	last	JJ	_	21	amod	_
21	week	week	NN	_	19	npadvmod	19:AM-TMP
22	it	it	PRP	_	24	nsubj	24:A0=PAG
23	has	have	VBZ	_	24	aux	_
24	received	receive	VBN	pb=receive.01	21	rcmod	_
25	$	$	$	_	26	nmod	_
26	26.5	0	CD	_	27	nn	_
27	m	m	NN	p2=VBN	24	dobj	24:A1=PPT
28	in	in	IN	_	27	prep	_
29	funding	funding	NN	p2=VBG	28	pobj	_
30	from	from	IN	_	24	prep	24:A2=DIR
31	Lilly	lilly	NNP	_	33	nn	_
32	Asia	asia	NNP	_	33	nn	_
33	Ventures	ventures	NNP	p2=NNPS	30	pobj	_
34	,	,	,	_	33	punct	_
35	a	a	DT	_	38	det	_
36	venture	venture	NN	_	38	nn	_
37	capital	capital	NN	_	38	nn	_
38	group	group	NN	_	33	appos	39:A1=PPT
39	affiliated	affiliate	VBN	pb=affiliate.01	38	partmod	_
40	with	with	IN	_	39	prep	39:A2=PPT
41	Eli	eli	NNP	_	42	nn	_
42	Lilly	lilly	NNP	_	40	pobj	_
43	.	.	.	_	19	punct	_

1	The	the	DT	_	2	det	_
2	investment	investment	NN	_	5	nsubjpass	5:A1=PPT;7:A2=VSP
3	is	be	VBZ	_	5	aux	_
4	being	be	VBG	_	5	auxpass	_
5	used	use	VBN	pb=use.01	28	ccomp	28:A1=PPT
6	to	to	TO	_	7	aux	_
7	fund	fund	VB	pb=fund.01	5	xcomp	5:A2=PRP
8	rapid	rapid	JJ	_	9	amod	_
9	expansion	expansion	NN	_	7	dobj	7:A1=PPT
10	of	of	IN	_	9	prep	_
11	the	the	DT	_	12	det	_
12	CRO	cro	NNP	p2=NN	16	poss	_
13	's	's	POS	_	12	possessive	_
14	translational	translational	JJ	p2=NN	16	amod	_
15	oncology	oncology	NN	p2=IN	16	nn	_
16	platforms	platform	NNS	_	10	pobj	_
17	,	,	,	_	16	punct	_
18	including	include	VBG	_	16	prep	_
19	the	the	DT	_	20	det	_
20	development	development	NN	_	18	pobj	_
21	of	of	IN	_	20	prep	_
22	Crown	crown	NNP	_	25	poss	_
23	's	's	POS	_	22	possessive	_
24	mice	mouse	NNS	p2=NN	25	nn	_
25	models	model	NNS	_	21	pobj	_
26	,	,	,	_	28	punct	_
27	Li	li	NNP	_	28	nsubj	28:A0=PAG
28	told	tell	VBD	pb=tell.01	0	root	_
29	us	us	PRP	_	28	dobj	28:A2=GOL
30	.	.	.	_	28	punct	_

1	The	the	DT	_	2	det	_
2	head	head	NN	_	6	nsubj	6:A0=PAG
3	of	of	IN	_	2	prep	_
4	Translational	translational	NNP	p2=JJ	5	nn	_
5	Oncology	oncology	NNP	_	3	pobj	_
6	told	tell	VBD	pb=tell.01	0	root	_
7	us	us	PRP	_	6	dobj	6:A2=GOL
8	it	it	PRP	_	11	nsubj	_
9	would	would	MD	_	11	aux	11:AM-MOD
10	also	also	RB	_	11	advmod	11:AM-ADV
11	take	take	VB	pb=take.01	6	ccomp	6:A1=PPT
12	advantage	advantage	NN	_	11	dobj	11:A1=PPT
13	of	of	IN	_	11	prep	11:A2=DIR
14	NRCMM	nrcmm	NNP	_	18	poss	_
15	's	's	POS	_	14	possessive	_
16	other	other	JJ	_	18	amod	_
17	mice	mouse	NNS	p2=NN	18	nn	_
18	models	model	NNS	_	13	pobj	_
19	.	.	.	_	6	punct	_

1	"	"	``	_	3	punct	_
2	They	they	PRP	_	3	nsubj	3:A0=PAG
3	have	have	VBP	pb=have.03	0	root	_
4	a	a	DT	_	6	det	_
5	GEMM	gemm	NNP	p2=NN	6	nn	_
6	model	model	NN	_	3	dobj	3:A1=PPT
7	with	with	IN	_	6	prep	_
8	mouse	mouse	NN	_	9	nn	_
9	immunity	immunity	NN	_	7	pobj	_
10	.	.	.	_	3	punct	_

1	In	in	IN	_	8	prep	8:AM-TMP
2	recent	recent	JJ	_	3	amod	_
3	years	year	NNS	_	1	pobj	_
4	,	,	,	_	8	punct	_
5	immune	immune	JJ	_	6	amod	_
6	therapy	therapy	NN	_	8	nsubj	8:A1=PPT
7	has	have	VBZ	_	8	aux	_
8	become	become	VBN	pb=become.01	0	root	_
9	a	a	DT	_	11	det	_
10	huge	huge	JJ	_	11	amod	_
11	promise	promise	NN	_	8	attr	8:A2=PRD
12	in	in	IN	_	11	prep	_
13	cancer	cancer	NN	_	14	nn	_
14	therapy	therapy	NN	_	12	pobj	_
15	.	.	.	_	8	punct	_
16	"	"	''	_	8	punct	_

1	Crown	crown	NNP	p2=NN	2	nsubj	2:A0=PAG;4:A0=PAG;13:A0=PAG
2	plans	plan	VBZ	pb=plan.01	28	ccomp	28:A1=PPT
3	to	to	TO	_	4	aux	_
4	access	access	VB	p2=NN|pb=access.01	2	xcomp	2:A1=PPT
5	NCRMM	ncrmm	NNP	_	9	poss	_
6	's	's	POS	_	5	possessive	_
7	existing	exist	VBG	pb=exist.01	9	amod	_
8	mouse	mouse	NN	_	9	nn	_
9	models	model	NNS	_	4	dobj	4:A1=PPT;7:A1=PAG
10	and	and	CC	_	4	cc	_
11	to	to	TO	_	13	aux	_
12	further	far	RB	_	13	advmod	13:AM-EXT
13	develop	develop	VB	pb=develop.02	4	conj	_
14	them	them	PRP	_	13	dobj	16:A0=PAG;13:A1=PRD
15	to	to	TO	_	16	aux	_
16	derive	derive	VB	pb=derive.01	13	advcl	_
17	a	a	DT	_	18	det	_
18	version	version	NN	_	16	dobj	16:A1=PPT;22:A1=PPT
19	that	that	WDT	_	22	nsubjpass	22:R-A1
20	can	can	MD	_	22	aux	22:AM-MOD
21	be	be	VB	_	22	auxpass	_
22	used	use	VBN	pb=use.01	18	rcmod	_
23	by	by	IN	_	22	agent	22:A0=PAG
24	clients	client	NNS	_	23	pobj	25:A0=PAG
25	exploring	explore	VBG	pb=explore.01	24	partmod	_
26	immunotherapies	immunotherapy	NNS	_	25	dobj	25:A1
27	,	,	,	_	28	punct	_
28	said	say	VBD	pb=say.01	0	root	_
29	Li	li	NNP	_	28	nsubj	28:A0
30	.	.	.	_	28	punct	_

1	NRMCC	nrmcc	NNP	p2=NN	3	nsubj	3:A0=PAG
2	also	also	RB	_	3	advmod	3:AM-DIS
3	has	have	VBZ	pb=have.03	13	ccomp	13:A1=PPT
4	a	a	DT	_	6	det	_
5	large	large	JJ	_	6	amod	_
6	collection	collection	NN	_	3	dobj	3:A1=PPT
7	of	of	IN	_	6	prep	_
8	mice	mouse	NNS	p2=NN	7	pobj	_
9	for	for	IN	_	6	prep	_
10	diabetes	diabetes	NN	p2=NNS	11	nn	_
11	studies	study	NNS	_	9	pobj	_
12	,	,	,	_	13	punct	_
13	said	say	VBD	pb=say.01	0	root	_
14	Li	li	NNP	_	13	nsubj	13:A0
15	,	,	,	_	13	punct	_
16	and	and	CC	_	13	cc	_
17	there	there	EX	_	18	expl	_
18	is	be	VBZ	pb=be.02	13	conj	_
19	"	"	``	_	20	punct	_
20	potential	potential	JJ	p2=NN	18	attr	18:A1=PPT
21	"	"	''	_	20	punct	_
22	for	for	IN	_	26	mark	_
23	the	the	DT	_	24	det	_
24	companies	company	NNS	_	26	nsubj	26:A0=PAG;34:A0=PAG
25	to	to	TO	_	26	aux	_
26	collaborate	collaborate	VB	pb=collaborate.01	20	advcl	_
27	in	in	IN	_	26	prep	26:A1=COM
28	this	this	DT	_	30	det	_
29	therapeutic	therapeutic	JJ	_	30	amod	_
30	area	area	NN	_	27	pobj	_
31	as	as	RB	_	32	advmod	_
32	well	well	RB	_	26	advmod	26:A2=PPT
33	,	,	,	_	26	punct	_
34	adding	add	VBG	pb=add.02	26	advcl	26:AM-ADV
35	to	to	IN	_	34	prep	34:A2=PPT
36	Crown	crown	NNP	_	38	poss	_
37	's	's	POS	_	36	possessive	_
38	cohort	cohort	NN	p2=JJ	35	pobj	_
39	of	of	IN	_	38	prep	_
40	diabetes	diabetes	NN	_	41	nn	_
41	monkeys	monkey	NNS	_	39	pobj	_
42	.	.	.	_	18	punct	_

1	The	the	DT	_	3	det	_
2	Chinese	chinese	JJ	p2=NNPS	3	amod	_
3	organisation	organisation	NN	_	4	nsubj	4:A1=PPT
4	is	be	VBZ	pb=be.01	0	root	_
5	a	a	DT	_	6	det	_
6	non-profit	non-profit	JJ	p2=NN	4	attr	8:A1=PPT;4:A2=PRD
7	heavily	heavily	RB	p2=NN	8	advmod	8:AM-MNR
8	funded	fund	VBN	p2=JJ|pb=fund.01	6	partmod	_
9	by	by	IN	_	8	agent	8:A0=PAG
10	the	the	DT	_	12	det	_
11	Chinese	chinese	JJ	_	12	amod	_
12	government	government	NN	_	9	pobj	_
13	.	.	.	_	4	punct	_

1	It	it	PRP	_	3	nsubj	3:A0=PAG
2	also	also	RB	_	3	advmod	3:AM-DIS
3	has	have	VBZ	pb=have.03	0	root	_
4	a	a	DT	_	6	det	_
5	commercial	commercial	JJ	_	6	amod	_
6	wing	wing	NN	_	3	dobj	3:A1=PPT
7	.	.	.	_	3	punct	_

1	Crown	crown	NNP	p2=NN	2	nn	_
2	Biosciences	biosciences	NNP	p2=NNPS	4	nsubj	4:A0=PAG
3	has	have	VBZ	_	4	aux	_
4	partnered	partner	VBN	pb=partner.01	0	root	_
5	with	with	IN	_	4	prep	_
6	China	china	NNP	_	9	poss	_
7	's	's	POS	_	6	possessive	_
8	biggest	big	JJS	_	9	amod	_
9	producer	producer	NN	_	5	pobj	_
10	of	of	IN	_	9	prep	_
11	mutant	mutant	JJ	_	12	amod	_
12	mice	mouse	NNS	_	10	pobj	_
13	to	to	TO	_	14	aux	_
14	build	build	VB	pb=build.01	4	xcomp	4:A1=COM
15	better	well	RBR	p2=JJR	17	amod	_
16	experimental	experimental	JJ	_	17	amod	_
17	models	model	NNS	_	14	dobj	14:A1=PRD
18	for	for	IN	_	17	prep	_
19	its	its	PRP$	_	22	poss	_
20	cancer	cancer	NN	_	21	nn	_
21	research	research	NN	_	22	nn	_
22	sponsors	sponsor	NNS	_	18	pobj	_
23	,	,	,	_	17	punct	_
24	as	as	IN	_	14	prep	_
25	part	part	NN	_	24	pobj	_
26	of	of	IN	_	25	prep	_
27	its	its	PRP$	_	36	poss	_
28	$	$	$	_	30	quantmod	_
29	26.5	0	CD	_	30	number	_
30	m	m	CD	p2=NN	36	nn	_
31	(	(	-LRB-	_	36	punct	_
32	£16	£0	CD	p2=NN	33	num	_
33	m	m	NN	p2=LS	36	nn	_
34	)	)	-RRB-	_	36	punct	_
35	venture	venture	NN	_	36	nn	_
36	funding	funding	NN	_	26	pobj	_
37	.	.	.	_	4	punct	_

1	Get	get	VB	pb=get.01	0	root	_
2	FREE	free	JJ	_	3	amod	_
3	access	access	NN	_	1	dobj	1:A1=PPT
4	to	to	IN	_	3	prep	_
5	authoritative	authoritative	JJ	_	7	amod	_
6	breaking	breaking	NN	p2=JJ	7	nn	_
7	news	news	NN	_	4	pobj	_
8	,	,	,	_	7	punct	_
9	videos	video	NNS	_	7	conj	_
10	,	,	,	_	9	punct	_
11	podcasts	podcast	NNS	_	9	conj	_
12	,	,	,	_	11	punct	_
13	webinars	webinars	NNS	p2=JJ	11	conj	_
14	and	and	CC	_	13	cc	_
15	white	white	JJ	_	16	amod	_
16	papers	paper	NNS	_	13	conj	_
17	.	.	.	_	1	punct	_

1	©	©	NNP	p2=``	6	nn	_
2	William	william	NNP	_	6	nn	_
3	Reed	reed	NNP	_	6	nn	_
4	Business	business	NNP	_	5	nn	_
5	Media	media	NNP	_	6	nn	_
6	SAS	sas	NNP	_	0	root	_
7	2014	0	CD	_	6	num	_
8	,	,	,	_	11	punct	_
9	All	all	DT	_	10	det	_
10	rights	right	NNS	_	11	nsubj	11:A0=PAG
11	reserved	reserve	VBN	p2=VBD|pb=reserve.01	0	root	_
12	.	.	.	_	11	punct	_

1	This	this	DT	_	2	det	_
2	site	site	NN	_	3	nsubj	3:A0=PAG
3	uses	use	VBZ	pb=use.01	0	root	_
4	cookies	cookie	NNS	_	3	dobj	3:A1=PPT
5	.	.	.	_	3	punct	_

1	By	by	IN	_	0	root	_
2	continuing	continue	VBG	pb=continue.01	1	pcomp	_
3	to	to	TO	_	4	aux	_
4	browse	browse	VB	pb=browse.01	2	xcomp	2:A1=PPT
5	the	the	DT	_	6	det	_
6	site	site	NN	_	4	dobj	4:A1=PPT
7	you	you	PRP	_	9	nsubj	9:A0=PAG
8	are	be	VBP	_	9	aux	_
9	agreeing	agree	VBG	pb=agree.01	6	rcmod	_
10	to	to	IN	_	9	prep	9:A1=PPT
11	our	our	PRP$	_	12	poss	_
12	use	use	NN	_	10	pobj	_
13	of	of	IN	_	12	prep	_
14	cookies	cookie	NNS	_	13	pobj	_
15	.	.	.	_	1	punct	_

1	Find	find	VB	pb=find.03	0	root	_
2	out	out	RP	p2=RB	1	prt	1:C-V
3	more	more	JJR	p2=RBR	4	advmod	_
4	here	here	RB	_	1	advmod	1:AM-LOC
5	.	.	.	_	1	punct	_

